Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 60
Summary
- Conditions
- Brain Metastases, Adult
- Clear Cell Metastatic Renal Cell Carcinoma
- Melanoma
- Non Small Cell Lung Cancer Metastatic
- Small Cell Lung Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02978404
- Collaborators
- Bristol-Myers Squibb
- Investigators
- Principal Investigator: Philip Wong, MD, FRCPC Centre hospitalier de l'Université de Montréal (CHUM)